EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Changing of the Guard: 10 New CEOs in New England Tech, Life Sciences, and Energy

‘Tis the season for new chief executives in the Boston area. In the past month or so, we’ve seen no fewer than 10 newly announced CEOs at technology, life sciences, and cleantech companies. So we thought we’d round them up and look for any interesting patterns.

It’s a pretty good mix of public (4) and private (6) companies. Five are in software/tech, while three are biotech/life sciences, and there’s one each in energy and manufacturing. Nothing too surprising or unusual here that we can see—just leadership changes that typically come with companies evolving in a challenging economy.

In some cases—such as Apperian, Memento, and Verdasys—the incoming CEO succeeds a founder of the company in the new role. One CEO, Richard Feldt, shows up twice in the list—he left the helm of Evergreen Solar and has joined manufacturing tech firm Advanced Electron Beams. I’m sure there are others we’ve neglected to mention, so please leave a comment or drop us a note if you have a tip.

Here’s the quick rundown of the new people and their companies, in reverse chronological order of when they were announced, so the most recent changes are on top (previous CEOs listed in parentheses):

ADI Time
East Providence, RI
John DiPippo (John Volatile)

Idenix Pharmaceuticals (NASDAQ: IDIX)
Cambridge, MA
Ronald Renaud (Jean-Pierre Sommadossi)

Memento
Burlington, MA
John O’Malley (BC Krishna) … Next Page »

Single PageCurrently on Page: 1 2